Research Article

Association between polymorphisms in TLR4 gene targeted by microRNA-140 and cervical precancerous lesion in south Chinese women: a case control study

Received: September 10, 2017
Accepted: October 30, 2017
Published: November 29, 2017
Genet.Mol.Res. 16(4): gmr16039831
DOI: 10.4238/gmr16039831


Toll-like receptor 4 (TLR4), one of the key immune system effectors, plays a main role in immune recognition of cervical cancer. Micro-RNAs are involved in regulation of multiple important genes in the progression of cervical cancer. A case-control study of 592 people was conducted from Yun’an County, Yunfu City, Guangdong Province, China. Cervical fall off epithelia were collected to detect human papilloma virus (HPV), followed by Thin Prep cytology test (TCT). Moreover, extraction of DNA from peripheral blood were performed for genotyping from the 296 patients and another 296 age-matched healthy control subjects. Logistic regression was used to determine the risk genotypes for susceptibility to cervical precancerous lesion, and multifactor dimensionality reduction (MDR) was further employed to preliminarily investigate the gene-environment interaction on risk of cervical precancerous lesion. Gene expression of miRNA-140 from serum was done by real-time PCR. We investigated whether target sites of TLR4 gene polytheisms (rs11536896 T>C, rs7873784 G>C) of miR-140 were associated with cervical precancerous lesion risk. The alleles C>A of SNP rs11536896 were significantly different in ASCUS in comparison of case group and control group with HPV infection. The presence of the allele C was associated with a higher risk of developing ASCUS lesion in HPV negative women (OR: 1.75, 95%CI:1.20-2.54, p = 0.003). There was statistically significant difference between the expression of miRNA 140 and the susceptibility to cervical precancerous lesion, in which there is down-regulation of the miRNA-140 in case group (T=6.73,P=0.007). Gene-environment interaction analysis by MDR software revealed an association among rs7873784 and hrHPV infection and more types of infected HPV (p < 0.0001, OR: 25.48; 95%Cl: 5.20-124.84). Collectively, these results suggested that rs11536896 and rs787378 from TLR4 gene were associated with risks of cervical precancerous lesion. Thus, this miRNA-140 and SNPs(rs11536896rs787378) of TLR4 gene could be considered as a potential molecular mechanism and biomarker for detecting and diagnosing cervical cancer in early time


Cervical cancer is one of the most common malignancies in women, accounting for an estimated 52,800 new cases and 266,000 deaths globally in 2012(International agency for research on cancer. Globocan 2012) Accumulating evidence have showed that human papilloma virus (HPV) infection, especially high-risk types of HPV (hrHPV) infection, is an necessary cause in over 95% of cases (Walboomers et al. 1999). Most people who have had HPV infection, however, do not develop malignancy, only a part of them would ultimately suffer from cervical cancer (Winer et al. 2003). Therefore, HPV-induced carcinogenesis in the development of cervical cancer is highly complex, with its underlying molecular mechanisms remaining unclarified. It typically takes up to 20-30 years for precancerous lesions (CIN1-3) to further develop to cervical cancer following a hrHPV infection, during which period early diagnosis and intervention can be carried out. Therefore, it is worthwhile exploring and clarifying the problems of cervical precancerous lesions.

However, HPV infection alone is not sufficient to initiate cervical cancer. The transition from HPV infection to cervical cancer is affected by various factors, including harmful lifestyle, related immune response, and genetic susceptibility. While the majority of cervical cancers are caused by HPV infection, other contributing factors, such as immune systems and genetic susceptibility, also play an important role in dictating predisposition to cervical cancer (Wang et al. 2009; Zidi et al. 2015).

Toll-like receptors (TLRs), a family of important pattern recognition receptors in innate immune system, can identify conservative antigen molecules derived from pathogenic microorganisms, such as lipopolysaccharide (LPS), a pathogen nucleic acid (R. Yang et al. 2005). A large number of studies have already shown that HPV infection not only leads to an exception the expression of TLRs receptor,but also promotes its mediated signaling pathways, which is related to molecular interaction in cancer progression(Werner et al. 2012; Zhou, Zhu, & Cheng, 2013). During the process, TLR-4 contributes to recognize HPV16 Virus-like particles (VLPs) via TLR4 - Myd88 pathway to activate the Nuclear factor kB (NF-kB), subsequently inducing CD4+T cell activation, and producing a series of cytokines to eliminate viruses(Mai, Kang, & Pichika, 2013). A significant decrease was observed in the relative gene expression of TLR-4 in patients with cervical cancer (Aggarwal et al. 2015). Taken together, we cautiously speculate that TLR-4 plays a key role in the occurrence and progression of cervical precancerous lesions.

More and more recent studies have reported an association among genetic susceptibility, non-coding RNAs and the formation, development of many tumors. Of note, microRNAs (miRNAs), a class of short non-coding RNAs, are highly efficient regulators of gene expression via an interaction with the 3'-UTR of their target mRNAs in various cellular processes (Zorc et al. 2012). miRNA-140, a newly discovered miRNA, played a role in osteoarthritis at first (Miyaki et al. 2009), further, miRNA-140 has been reported to be involved in the development of cervical cancer (Jing, Sa, & Xu, 2016; Su et al. 2016).

In addition, single-nucleotide polymorphisms (SNPs) located in the 3'-UTRs of genes may affect interactions with miRNAs, whose association with tumorigenesis is currently a focus of research. One miRNA targets numerous messenger RNAs (mRNAs), and one mRNA may be regulated by more than one miRNA. Therefore, functional variations, such as SNPs located in the 3'-UTRs of cancer-associated genes, may cause differential regulation of target gene expression and simultaneously alter numerous molecular pathways that are associated with tumorigenesis. However, SNPs of the 3'-UTR region of the TLR4 gene have rarely been investigated, which deserves further work. Thus, our study was designed to evaluate the possible association of the SNP in the miRNA-140 targeting site of TLR4 with the development of cervical lesions in women with HPV infection.

Materials and Methods

Study population

Two hundred ninety-six sexually active women, with mean age of 42.07±8.45 years old (ranging from 18 to 68 years old), were collected in the study, who were screened in Family Planning Service Stations of Yun’an County, Yunfu City, Guangdong Province, China, between June, 2013 and August, 2014. All enrolled patients presented different grades of cervical intraepithelial neoplasia (ASCUS, LSIL, HSIL), which were confirmed by histological and cytological analysis. The Bethesda System was used for cytological diagnostic criteria and WHO (2014) was utilized for histologic diagnostic criteria.

Two hundred ninety-six age-matched healthy control subjects were healthy women, with mean age 43.10±7.28 years old (ranging from 14 to 70 years old), but without cervical lesions, who came to Family Planning Service Stations for the screening during the same period and of the same region. Those healthy subjects, without no history of lesions or tumors which were evaluated by the physician, were enrolled as controls, and provided written, informed consent.

A total of 592 participants finished a questionnaire, including demographic data (including age), BMI, family history of cancer, gynecological history, passive smoking status (day/week), age at menarche (year), age at first sexual intercourse (year), age at first pregnancy (year), pregnant frequency, abortive frequency, HPV infection, and numbers of infected HPV types. The protocol of this study was approved by the research ethics committee of the Family Planning Specialized Hospital of Guangdong Province and all participants provided with written, informed consent.

HPV Genotyping Text

The DNA of HPV was detected by nested PCR using two rounds of amplification, yielding a 150 bp PCR amplicon that included a conserved sequence of the viral genome. The primers for first round, and second round were MY09/11, and GP 05/06+, respectively. GP06 primers were biotinylated for later PCR enzyme immune assay. Protocol and cycling conditions for DNA amplification were described elsewhere. PCR products were electrophoresed in 2 % agarose gels, stained with SaferGreen™ (Invitrogen) and visualized in blue light by SafeImager™ (Invitrogen).

DNA extraction

Two SNPs, rs11536896 and rs7873784 in the TLR-4 gene were included in our study. Genomic DNA was extracted from EDTA anti-coagulated peripheral blood according to a standard proteinase K digestion and phenol chloroform extraction method (Javadi et al. 2014). Eventually, the extraction of DNA was resolved in Elution Buffer and stored at −20 °C.

RNA extraction and RT-PCR

The blood was mixed with a one-quarter volume of 2% dextran solution (MW 464 000 Da; Sigma-Aldrich, St Louis, MO, USA) and incubated at room temperature for 30 min. Total RNA, including miRNA, was extracted from the purified T cells using the mirVana miRNA isolation kit (Ambion,Austin, TX, USA), according to the manufacturer’s protocol. The concentration of RNA was quantified using a NanoDrop Spectrophotometer. All the extracted miRNAs were converted into corresponding cDNAs Briefly, a 10μl reaction mixture containing miRNA-specific stem-loop RT primers (final concentration 2 nM each), 500 μM deoxyribonucleotide triphosphates (dNTPs), 0.5 μl Superscript III (Invitrogen, Carlsbad, CA, USA) and 1 μg total RNA were used for the reverse transcription (RT) reaction.The pulsed RT reaction was performed under the followingconditions: 16°C for 30 min, followed by 50 cycles at 20°C for 30 s, 42°C for 30 s and 50°C for 1s. After RT, the products were diluted 20-fold before further analysis. A real-time PCR-based method was used to quantify the expression levels of miRNAs using a protocol described previously. The prepared RT product (1μl) was used as the PCR template. Each PCR reaction contained 1 × SYBR Master Mix (Applied Biosystems, Foster City, CA, USA), 200 nM miRNA-specific forward primer and 200nM universal reverse primer. All reactions were performed in duplicate on an ABI 7500 fast real-time PCR system (Applied Biosystems). The conditions for quantitative PCR were 95°C for 2 min, followed by 40 cycles of 95°C for 15 s and 62°C for 32 s. There primers as follow: hsa-miR-140 F: 5’ACACTCCAGCTGGGCAGTGGTTTTACCCTATG

R:            5’CTCAACTGGTGTCGTGGA,                  U6                  F:5’CTCGCTTCGGCAGCACA                  R:5’AACGCTTCACGAATTTGCGT.

HPV Typing

Cervical scraping smear was genotyped using the HPV Geno Array test kit (The Beijing Genomics Institute, BGI, Guangdong, China). The presence of various HPV types was amplified with the L! consensus HPV primers MY09/MY11 and HMB01. Then, the flow-through hybridization was performed using PCR product in the manner of a microarray format with a nylon membrane, on which, HPV genotype-specific oligonucleotide probes were immobilized (Yoshikawa et al. 1991). Sixteen HPV types can be detected by the technique, including HPV16, HPV18, HPV35, HPV31, HPV33, HPV51, HPV39, HPV45, HPV58, HPV59, HPV52, HPV56, HPV66, and HPV68 (all HR HPV), as well as HPV6 and HPV11 (both LR HPV) (Venturoli et al. 2002). All these procedures were performed in the clinical standard laboratory of BGI.

SNPs Screening

The information of two SNPs targeted by miRNA was detected from website in combines miR Base sequence database( and PubMed (

Two predictable miRNA target genes of the TLR4 rs11536896, rs787378, were found by software, including miRanda ( and Target Scan.

(http:/ screening SNPs have to meet the following conditions, minimum allele frequency in the Chinese Han nationality to SNP minor allele frequency (MAF) > 0.05, and the SNPs located in the matching area of microRNAs with target genes.

LD analysis

A total of two SNPs across the TLR4 loci were analyzed. The linkage disequilibrium (LD plot) of the SNPs in the TLR4 genes of patients with cervical precancerous lesion was shown in Figure 1. Linkage disequilibrium (LD) analyses gave D’ values and r2 values, suggesting that two of the TLR4 SNPs loci were in LD. The haplotype block was based on confidence intervals D’. Each diamond represented the pairwise magnitude of LD, with red indicating strong LD (D’ > 0.8) and logarithm of odds score (LOD) ≥ 2.0 (D’ = 0.92, LOD = 104.56, r2 = 0.83) (Figure 1).


Figure 1: LD analysis of patients with cervical precancerous lesion

Statistical analysis

Initially, the departure of frequencies of two DNAs (rs11536896, rs7873784) polymorphisms from expectation under Hardy-Weinberg equilibrium (HWE) for tested genotype distributions was assessed using chi-square goodness of fit test in controls. Logistic regression was further used to establish the association between the gentic polymorphisms of miRNA target genes site of TLR-4 rs11536896 and rs7873784 and risk of pre-cervical cancer by calculating odds (ORs), 95% confidence intervals (95%Cl), and their corresponding p values. Moreover, gene-environment interaction in risk of cervical precancerous lesion was evaluated by multifactor dimensionality reduction (MDR, V3.0.2). Finally, joint effect of TLR4 gene polymorphisms in the analysis by the number of risk genotypes was evaluated using conditional logistic regression models. Haplotypes of the TLR4 SNPs were assessed using HaploView 4.2 Software (Barrett et al. 2005). A p value<0.05 was considered as statistically significant. All the statistical analyses were performed using the SPSS 17.0.


General characteristics of population

There were no significant differences in distributions of age, family history of cancer, Gynecological history, age at first pregnancy, abortive frequency between cases and controls (p > 0.05) However, BMI, passive smoking status, age at menarche, age at first sexual intercourse, pregnant frequency, HPV infection and numbers of infected HPV types in case group were significantly different from those in control group(p < 0.05)(shown in Table1). Therefore, these variables were subsequently adjusted for any residual confounding effect in unconditional logistic regression analyses.

Characteristics Case group Control group T/X2 p-value
No. % No. %    
  <18.5 41 13.85 18 6.08 10.01 0.007a
18.5-25 220 74.32 238 80.41    
  ≥25 35 11.82 40 13.51    
Family history of cancer            
Positive 1 0.34 4 1.35   0.373b
Negative 295 99.66 292 98.65    
Gynecological history            
Positive 171 57.77 166 56.08 0.17 0.678a
Negative 125 42.23 130 43.92    
Passive smoking status(day/week)            
6-7 69 23.31 43 14.53 9.19 0.027a
4-5 30 10.14 36 12.16    
1-3 42 14.19 58 19.59    
<1 155 52.36 159 53.72    
Age at menarche (year)            
<16 167 56.42 199 67.23 7.33 0.007a
≥16 129 43.58 97 32.77    
Age at first sexual intercourse(year)            
<20 18 3.09 36 47.68 6.60 0.010a
≥20 278 6.17 260 43.05    
Age at first pregnancy(year)            
≤21 76 3.09 70 47.68 0.33 0.567a
>21 220 6.17 226 43.05    
Pregnant frequency            
≤3 222 76.14 244 82.15 4.21 0.040a
>3 73 23.86 53 17.85    
Abortive frequency            
Positive 238 40.82 261 44.77 3.26 0.071a
Negative 49 8.40 35 6.00    
HPV Infection            
Negative 82 27.70 204 68.92 101.65 0.000a
Infect low-risk HPV 3 1.01 3 1.02    
Infect high-risk HPV 211 71.28 89 30.07    
Type of infect HPV numbers            
  Negative 79 26.69 204 68.92 105.85 0.000a
1 186 62.84 80 27.03    
>2 31 10.47 12 4.05    
Mean ± SD 42.07±8.45 43.10±7.28 1.74 0.082c

Table 1: Demographic characteristics

In this study, 296 cases and 296 controls from Southern China population were analyzed for the association between TLR4 polymorphisms and cervical precancerous lesions. The distribution of the two SNPs genotypes in TLR4 and their associations with cervical precancerous lesion risk were shown in Table 2. The genotypic distributions of the two studied SNPs were both in accordance with Hardy–Weinberg equilibrium (p > 0.05) in controls. There were no differences in the genotypic distribution of TLR4 rs11536896, rs7873784 between cases and controls. Further, logistic regression analyses were utilized, which failed to reveal any significant difference in any phenotypes and gene models after adjusting the variables, including BMI, passive smoking status, age at menarche, age at first intercourse, pregnant frequency.

TLR4   Cases Controls OR (95% CI) P OR (95% CI)a Pa Pb
rs11536896               0.148
Codominant model TT 232 223 1   1    
  TC 57 71 0.77(0.52-1.14) 0.197 0.77(0.52-1.16) 0.211  
  CC 3 2 1.44(0.24-8.71) 0.690 1.94(0.31-11.98) 0.478  
Dominant model TT 232 223 1   1    
  TC+CC 60 73 0.79(0.54-1.16) 0.234 0.80(0.54- 1.19) 0.273  
Recessive model TT+TC 289 294 1   1    
  CC 3 2 1.53(0.25-9.20) 0.645 2.04(0.33-12.63) 0.442  
allele T 521 517 1        
  C 63 75 1.20(0.84-1.71) 0.316      
rs7873784               0.054
Codominant model GG 230 223 1   1    
  CG 61 72 0.82(0.56-1.21) 0.320 0.81(0.55- 1.21) 0.304  
  CC 2 1 1.94(0.18-21.54) 0.590 3.16(0.28-35.62) 0.353  
Dominant model GG 230 223 1   1    
  CG+CC 53 73 0.84(0.57-1.22) 0.363 0.84(0.56- 1.24) 0.376  
Recessive model GG+CG 291 295 1   1    
  CC 2 1 1.53(0.25-9.20) 0.645 3.30(0.29- 37.21) 0.334  
allele G 521 618 1        
  C 65 73 0.96(0.67-1.37) 0.819      

Table2. Association between rs11536896 and rs7873784 in TLR4 gene and risk of cervical precancerous lesions

Women with positive and negative results of TCT lesions were then stratified according to the status of HPV infection, and TLR4 SNPs were compared between the different subgroups, shown in Table 3, Table S2 and Table S3. There were significant differences in the alleles C>A of SNP rs11536896 in ASCUS in comparison of case group and control group with HPV infection, and the presence of the allele C was associated with a higher risk of developing ASCUS lesion in HPV negative women (OR: 1.75, 95%CI:1.20-2.54, p = 0.003). However, no difference was observed in other allele, genotypes between case group and control group.

TLR4 Controls ASCUS OR(95%CI) P LSIL  OR(95%CI) P HSIL. OR(95%CI) P
n % n % n % n %
TT 223 75.3 100 77.5 Ref 97 82.2 Ref   35 76.1 Ref
TC  71 24.0  29 22.5 0.91(0.56-1.49) 0.138  19 16.1 0.62(0.35- 1.08) 0.087 9 19.6 0.81(0.37- 1.76) 0.705
CC  2 0.7 0 0.0 0.99(0.98-1.00) 1.000  2 1.7 2.30(0.32-16.56) 0.589 2 4.3 6.37(0.87-47.71) 0.097
Dominant model 73 100 29 100 0.89(0.54-1.45) 0.628 21 100 0.66(0.39-1.14) 0.132 11 100  0.96(0.46- 1.99) 0.913
Recessive model 294 100 129 100 0.99(0.98-1.00) 1 116 100 0.40(0.06-2.83) 0.322 44 100 0.15(0.02-1.09) 0.089
T 517 87.3 229 79.8 Ref   213 90.3     79 85.9 Ref
C 75 12.7 58 20.2 1.75(1.20-2.54) 0.003* 23 9.7 0.74(0.45-1.22) 0.240 13 14.1 1.13(0.60- 2.14) 0.697
GG 223 75.3 97 75.2 Ref 97 80.8 Ref 36 81.8 Ref
CG 72 24.3 32 24.8 1.02(0.63-1.65) 0.930 21 17.5 0.67(0.39- 1.15) 0.146 8 18.2 0.51(0.23- 1.14) 0.096
CC 1 0.3 0 0.0 1.00(0.99-1.00) 1.000 2 1.7 4.60(0.41-51.31) 0.223 0 0.0 0.99(0.98- 1.00) 1.000
Dominant model 73 100 32 100 0.99(0.62-1.62) 0.98 23 100 1.32(0.82-2.34) 0.228 8 100 1.47(0.46-3.31) 0.346
Recessive model 295 100 129 100 1.00(0.99-1.00) 1.00 118 100 0.20(0.02-2.23) 0.201 44 100 1.00(0.99-1.00) 1.00
G 516 87.5 226 87.6 Ref   215 89.6 Ref   80 90.9 Ref
C 74 12.5 32 12.4 0.99(0.63-1.54) 0.955 25 10.4 0.81(0.50-1.31) 0.392 8 9.1 0.70(0.32-1.50) 0.354

Table 3. TLR4 SNP Polymorphisms Frequencies in the Control Group and in Patients with ASCUS, LSIL and HSIL

The expression of miRNA-140 in case and control groups was shown in Figure 2. There was statistically significant difference between miRNA-140 expression and the susceptibility to cervical precancerous lesion, in which there is down-regulation of the miRNA-140 in case group. Meanwhile, a significant correlation was found between miRNA-140 level and heterozygotes genotypes of TLR4 polymorphism (rs11536896, rs7873784) in cervical precancerous lesion group (Table 4). However,there are not differences in rs11536896, rs7873784 mutants.


Figure 2: The miRNA-140 expression in cases and controls. Results are expressed as mean ± S.D. *P<0.05.The results were expressed as mean ± SD.

Allele N MiRNA-140 relative P- value
Mean SD
TT(Wild) 12 0.000073523 0.0000338413  
TC(heterozygotes) 7 0.000044576 0.0000075206 0.003
CC (mutant) 1 0.000031814    
GG(Wild) 11 0.000077129 0.0000329872  
CG(heterozygotes) 7 0.000044576 0.0000075206 0.008
CC (mutant) 2 0.000032837 0.0000014481 0.225

Table 4. Comparisons of relative in microRNA-140 indifferent genotyping

A variety of factors were executed with MDR analysis, including two SNPs of TLR4 (rs11536896, rs7873784), family history of cancer, passive smoking status, age at menarche, age at first sexual intercourse, pregnant frequency, age at first pregnancy, abortive frequency, HPV infection, numbers of infected HPV types, BMI and Gynecological history (Table 5).

model Training bal. acc Testing bal. acc CV consistency X2 P OR
Infect HPV 0.7128 0.6702 5/10 7.13 <0.001 4.38( 1.46- 13.10)
Infect HPV, BMI 0.7219 0.6640 5/10 114.43 <0.001 6.79( 4.71-  9.79)
Infect HPV, Types of infect HPV numbers, rs7873784 0.7755 0.7625 9/10 18.39 <0.001 25.48(5.20-124.84)
Infect HPV,  Types of infect HPV numbers, BMI, rs7873784 0.8044 0.7522 6/10 15.94 <0.001 14.31(3.84- 53.38)

Table 5. MDR models of rs11536896, rs7873784 those are association between SNPs and environmental factors

Consequently, rs7873784, HPV infection and numbers of infected HPV types were the strongest cervical cancer prediction model, with a maximum cross-validation consistency (CVC) of 9/10, relatively higher testing balance accuracy (TBA) of 0.7625, OR of 25.48(95% CI: 5.20-124.84), which suggested that the interaction of rs7873784, HPV infection and numbers of infected HPV types probably increased the risk of cervical cancer.


To date, various studies have investigated the association between SNPs in miRNA binding sites and cervical cancer risk. These studies shown that SNP in the 3' UTR of target genes may be significant to establishing the cancer risk of certain individual. However, no studies have yet shown that a link between genetic variations of the 3'UTR of the TLR4 gene to developing cervical precancerous lesions. In this study, we first study to investigate the possible association between the polymorphisms of miRNA-140 binding site of TLR4 gene and the presence of cervical lesions under various environmental factors in females from Yun’an County, Yunfu City, Guangdong Province, China.

In the TLRs family, TLR4 is expressed in some epithelial cells and plays an essential role in the defense against microbes by recognizing structurally conserved bacterial molecules. As reported by Wang et al. TLR4 expression may interact with HPV16 infection in the progression of cervical cancer, while LPS had no effect on cell cycle distribution (Y. Wang et al. 2014). Sabrina Zidi et al. reported TLR4 increased the risk of cervical neoplasm progression to advanced stages of cervical cancer when compared to the early stages (I+ II) (Zidi et al. 2015).

To the best of our knowledge, miR-140 was recognized as a tumor suppressor to regulating growth and metastasis of hepatocellular carcinoma by controlling NF-κB activity (H. Yang et al. 2013). miRNA-140 has been found to be down-regulated in multiple types of cancer, and suppresses cancer by targeting several important oncogenes like SOX2, DNMT1, TGFBR1 and FGF9(Su et al. 2016). Meanwhile, we predicted that the TLR4 gene exists miRNA-140 target regulation site by bioinformatics methods. Thus, we aimed to study the expression of miRNA-140 and its target gene TLR4 polymorphism (rs11536896, rs7873784) in pre-cancer patients in comparison to control subjects and to correlate these results with clinical data of patient group to explain their role in pathogenesis.

In our study, the alleles C in rs11536896 in ASCUS were significantly different in case group and control group with HPV infection, while the presence of the allele C was associated with a higher risk of developing ASCUS lesion in HPV negative women (OR: 1.75, 95%CI:1.20-2.54,P = 0.003). Increasing evidence has suggested that SNPs in the miRNA target gene sites may disturb or obstruct miRNAs function, subsequently affecting regulation of target genes expression, which is likely to involve in susceptibility to certain diseases, including cervical cancer and precancerous lesion (Xiong et al. 2011). In the present results, the minor C allele in TLR4- rs11536896 enhance the risk of cervical precancerous lesions. Considering SNPs located in the miRNA seed‑match region, affect the binding affinity of miRNA-140 to target mRNAs, causing differential regulation of target gene expression and altering numerous molecular pathways. The minor C allele may lead to changes in the TLR4 expression. The change of expression in TLR4 have been reported by a variety of studies (He et al. 2017), which may participate in carcinogenesis and tumor progression during chronic inflammation by shaping the tumor microenvironment. The mechanism requires further investigation in functional studies.

We found that there was a statistically significant association between miRNA-140 and the susceptibility to cervical precancerous lesion, that there is down-regulation of the miRNA-140 in case group. Our findings are consist with the study fromYang, H. et al. (Yang et al. 2013), in which miRNA-140 expression is frequently down-regulated in cervical cancer tissue and plasma samples compared to the non-tumor counterparts. In our study, miRNA-140 might reduce TLR4 activity by SNPs site. Another study revealed that miRNA-140 reduced cell migration and invasion of hypopharyngeal carcinoma cell by targeting down regulating ADAM10 expression (Jing et al. 2016).

Further, the two SNPs were statistically significant in two groups before we adjusted high-risk environmental factors. In recent report, TLR4 may serve as a candidate HPV-induced oncogene in cervical cancer and HR-HPVs may gain an advantage in inducing carcinogenesis by reshaping the environment of the cellular miRNA composition and target gene expression to benefit the virus (Jin et al. 2017). Therefore, the present study hypothesized that there is an interaction between HPV and each SNPs in the TLR4 gene, which is associated with the risk of cervical precancerous lesions. Studies showed that many environmental factors consumption were the risk in population, and we found environmental risk factors, which were not consistent to previous reports (Chang et al. 2014; L. D. Wang et al. 2014; White & Wong, 2015). This might be interpreted by the fact that gene susceptibility was variable in different ethnics. Hence, MDR model was used to analyze interaction between rs11536896, rs7873784 and environmental factors in the study, which indicated an interaction between HPV infection, numbers of infected HPV types and rs7873784. From the results, we concluded that the individuals with HPV infection, numbers of infected HPV types and rs7873784 were at high risk for developing cervical precancerous lesions, who deserve more attention in clinical practice.

Despite certain claims that the association between the SNPs of TLR4 gene related sites (including rs11536896 and rs7873784) and cancer development demands in-depth research, no other loci have been found to have significant correlations with cancer (Kutikhin, 2011; Weng et al. 2014). To the best our knowledge, it was the first study to investigate the association between two SNPs of TLR4 gene targeted by miR-140 and gene-environment interaction with cervical precancerous lesions risk. Cervical carcinoma is a complex disease, characterized by an intricate interplay of both genetic polymorphism and environmental factors (Yin et al. 2015). MDR analysis indicated that gene-environment interactions were likely to exist between rs7873784 and HPV infection, numbers of infected HPV types affecting the risk of cervical precancerous lesion, with synergistic effects on risk of cervical precancerous lesion. When it comes to the underlying mechanism, rs787384 may probably not only increase the risk of cervical precancerous lesion, but also enhance susceptibility of infecting high-risk HPV and more types of HPV. However, interactions between rs11536896 and other environmental factors were not found. Further, environmental factors and SNPs were pooled into two groups (high- and low-risk group) in MDR models, falling off the multifactor criterion predictors from impactive n dimensions to one dimension (Choudhury & Ghosh, 2015), which was a new method to investigate potential interactions of gene-environment models in human genetics and biological studies. The model overwhelms the others by reducing change of type 1 error better than traditional account methods in the multiple testing (Milne et al. 2008; Motsinger-Reif et al. 2008; Xu et al. 2014). The confounding bias from age was excepted in the study, because the groups of case and control were 1:1 matched by age (p> 0.05). According to Hardy-Weinberg equilibrium, result distribution of the genotype in the control groups as well as the selection bias were further avoided, which altogether made the findings in our study persuasive.

Nevertheless, there are certain limitations in the work. Firstly, miR-140 as a targeted microRNA with rs11536896, rs7873784 has not been proven by a religious experiment design or other research support.

Anyhow, it provides a good idea to test miR-140 as a new function in cervical neoplasm progression. Secondly, the sample size is relatively small to find a convincing association between SNPs and cervical precancerous lesion, which influences the reliability of the results. For example, there were only three participants in case group and two participants in control group, who harboured two SNPs CC (T to C and G to C). Finally, certain problems similar to other retrospective studies are not avoided in the study. Therefore, cohort study with a larger sample size are warranted, more data from laboratory should be collected to further explore the mechanisms of TLR4 in the cervical lesion.


The alleles C>A of SNP rs11536896 were significantly different in ASCUS in comparison of case group and control group with HPV infection. The presence of the allele C was associated with a higher risk of developing ASCUS lesion in HPV negative women (OR: 1.75, 95%CI: 1.20-2.54, P=0.003). there was statistically significant difference between miRNA-140 expression and the susceptibility to cervical precancerous lesion, in which there is down-regulation of the miRNA-140 in case group (T=6.73,P=0.007). Further, miRNA-140 may affect pre-cervical cancer development by binding affinity of miRNAs to target mRNAs, causing differential regulation of target gene expression and altering numerous molecular pathways. MDR analysis demonstrated an interaction between genetic variation rs7873784 in TLR4 gene and HPV infection, numbers of infected HPV types, which might be due to the increased risk of cervical precancerous lesion as well as the enhanced susceptibility of infection with high risk HPV and more types of HPV by rs787384. In conclusion, this miRNA-140 and it is targets SNPs (rs11536896, rs7873784) of TLR4 gene could be a potential molecular mechanism and biomarker.


The authors are indebted to all the donors whose names were not included in the author list, but who participated in our study.


This work was supported in part by China Population Welfare Foundation (grant number was [2011]31), Science and Technology Planning Project of Guangdong Province (grant number was 2013B032000001, 2014A020212546), Family Planning Foundation of Guangdong Province (grant number was 2012004), the Major Research Plan of the National Natural Science Foundation of China (Grant numbers: 91543132), National Natural Science Foundation of China (grant numbers: 30901249; 81101267; 81541070), the Guangdong Natural Science Foundation (grant numbers: 10151063201000036; S2011010002526), Guangdong Province Medical Research Foundation (grant n-umber: A2014374;A2015310) and Project from Jinan university (grant number: 21612-426,21615427 , JNUPHPM2016001, and JNUPHPM2016002).

About the Authors

Corresponding Author

Chunxia Jing

Department of Epidemiology, School of Medicine, Jinan University, Guangzhou, Guangdong Province, China

[email protected]

Xiangcai Wei

Department of Epidemiology, School of Medicine, Jinan University, Guangzhou, Guangdong Province, China

[email protected]


  • Aggarwal, R. Misra, S. Guleria, C. Suri, V. et al. (2015). Characterization of toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study. Gynecol Oncol, 138(2), 358-362.
  • Barrett, J. C. Fry, B. Maller, J. & Daly, M. J. (2005). Haploview: Analysis and visualization of ld and haplotype maps. Bioinformatics, 21(2), 263-265.
  • Chang, L. S. Leng, C. H. Yeh, Y. C. Wu, C. C. et al. (2014). Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy. Mol Cancer, 13, 60. http://doi: 10.1186/1476-4598-13-60.
  • Choudhury, J. H. & Ghosh, S. K. (2015). Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: A study of northeast indian population. J Oral Pathol Med, 44(7), 495-501.
  • He, A., Shao, J., Zhang, Y., Lu, H., et al. (2017). Cd200fc reduces lps-induced il-1beta activation in human cervical cancer cells by modulating tlr4-nf-kappab and nlrp3 inflammasome pathway. Oncotarget, 8(20), 33214-33224.
  • International agency for research on cancer. Globocan 2012: .). from sheets_cancer.aspx
  • Javadi, A. Shamaei, M. Mohammadi Ziazi, L. Pourabdollah, M. et al. (2014). Qualification study of two genomic DNA extraction methods in different clinical samples. Tanaffos, 13(4), 41-47.
  • Jin, Y. Qiu, S. Shao, N. & Zheng, J. (2017). Association of toll-like receptor gene polymorphisms and its interaction with hpv infection in determining the susceptibility of cervical cancer in chinese han population. Mamm Genome, 28(5-6), 213-219.
  • Jing, P. Sa, N. & Xu, W. (2016). mir-140-5p affects the migration and invasion of hypopharyngeal carcinoma cells by downregulating adam10 expression. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 51(3), 189-196.
  • Kutikhin, A. G. (2011). Impact of toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol, 72(2), 193-206.
  • Mai, C. W. Kang, Y. B. & Pichika, M. R. (2013). Should a toll-like receptor 4 (tlr-4) agonist or antagonist be designed to treat cancer? Tlr-4: Its expression and effects in the ten most common cancers. Onco Targets Ther, 6, 1573-1587.
  • Milne, R.L. Fagerholm, R. Nevanlinna, H. & Benitez, J. (2008). The importance of replication in gene-gene interaction studies: Multifactor dimensionality reduction applied to a two-stage breast cancer case-control study. Carcinogenesis, 29(6), 1215-1218.
  • Miyaki, S. Nakasa, T. Otsuki, S. Grogan, S. P. et al. (2009). Microrna-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum, 60(9), 2723-2730.
  • Motsinger-Reif, A. A. Fanelli, T. J. Davis, A. C. & Ritchie, M. D. (2008). Power of grammatical evolution neural networks to detect gene-gene interactions in the presence of error. BMC Res Notes, 1, 65.
  • Su, Y. Xiong, J. Hu, J. Wei, X. et al. (2016). Microrna-140-5p targets insulin like growth factor 2 mrna binding protein 1 (igf2bp1) to suppress cervical cancer growth and metastasis. Oncotarget, 7(42), 68397-68411.
  • Venturoli, S. Bonvicini, F. Cricca, M. Gallinella, G. et al. (2002). Evaluation of commercial kits for the detection and typing of human papillomavirus in cervical swabs. J Virol Methods, 105(1), 49-56.
  • Walboomers, J. M. Jacobs, M. V. Manos, M. M. Bosch, F. X. et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189(1), 12-19.<12::aid-path431>;2-f
  • Wang, L. D. Lam, W. W. Wu, J. & Fielding, R. (2014). Hong kong chinese women's lay beliefs about cervical cancer causation and prevention. Asian Pac J Cancer Prev, 15(18), 7679-7686.
  • Wang, S. S. Bratti, M. C. Rodriguez, A. C. Herrero, R. et al. (2009). Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis, 199(1), 20-30.
  • Wang, Y. Weng, Y. Shi, Y. Xia, X. et al. (2014). Expression and functional analysis of toll-like receptor 4 in human cervical carcinoma. J Membr Biol, 247(7), 591-599.
  • Weng, P. H. Huang, Y. L. Page, J. H. Chen, J. H. et al. (2014). Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: A systematic review and meta-analysis. PLoS One, 9(10), e110569.
  • Werner, J. Decarlo, C. A. Escott, N. Zehbe, I. et al. (2012). Expression of integrins and toll-like receptors in cervical cancer: Effect of infectious agents. Innate Immun, 18(1), 55-69.
  • White, M. C. & Wong, F. L. (2015). Preventing premature deaths from breast and cervical cancer among underserved women in the united states: Insights gained from a national cancer screening program. Cancer Causes Control, 26(5), 805-809.
  • Winer, R. L. Lee, S. K. Hughes, J. P. Adam, D. E. et al. (2003). Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol, 157(3), 218-226.
  • Xiong, F. Wu, C. Chang, J. Yu, D. et al. (2011). Genetic variation in an mirna-1827 binding site in mycl1 alters susceptibility to small-cell lung cancer. Cancer Res, 71(15), 5175-5181.
  • Xu, H. M. Sun, X. W. Qi, T. Lin, W. Y. et al. (2014). Multivariate dimensionality reduction approaches to identify gene-gene and gene-environment interactions underlying multiple complex traits. PLoS One, 9(9), e108103.
  • Yang, H. Fang, F. Chang, R. & Yang, L. (2013). Microrna-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology, 58(1), 205-217.
  • Yang, R. Murillo, F. M. Delannoy, M. J. Blosser, R. L. et al. (2005). B lymphocyte activation by human papillomavirus-like particles directly induces ig class switch recombination via tlr4-myd88. J Immunol, 174(12), 7912-7919.
  • Yin, G. Zhu, T. Li, J. Wu, A. et al. (2015). Cxcl12 rs266085 and tnf-alpha rs1799724 polymorphisms and susceptibility to cervical cancer in a chinese population. Int J Clin Exp Pathol, 8(5), 5768-5774.
  • Yoshikawa, H. Kawana, T. Kitagawa, K. Mizuno, M. et al. (1991). Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res, 82(5), 524-531.
  • Zhou, Q. Zhu, K. & Cheng, H. (2013). Toll-like receptors in human papillomavirus infection. Arch Immunol Ther Exp (Warsz), 61(3), 203-215.
  • Zidi, S. Sghaier, I. Gazouani, E. Mezlini, A. et al. (2015). Evaluation of toll-like receptors 2/3/4/9 gene polymorphisms in cervical cancer evolution. Pathol Oncol Res.
  • Zorc, M. Skok, D. J. Godnic, I. Calin, G. A. et al. (2012). Catalog of microrna seed polymorphisms in vertebrates. PLoS One, 7(1), e30737.

Full PDF